A Systematic Review of Exocrine Pancreatic Insufficiency Prevalence and Treatment in Type 1 and Type 2 Diabetes
Authors' conclusion
Cumulatively, this suggests there may be significant numbers of people with diabetes with EPI who are undiagnosed.
Study context
- Population
- People with T1D and T2D; studies of exocrine pancreatic insufficiency (EPI) prevalence and treatment
- Comparison
- T1D vs T2D vs Diabetes type not specified vs Without diabetes
- Outcome
- Prevalence of EPI
Pooled result
As reported in the abstract
- Without-diabetes prevalence comparable with other estimated general population EPI prevalence rates
- 10%-20%
Original publication
A Systematic Review of Exocrine Pancreatic Insufficiency Prevalence and Treatment in Type 1 and Type 2 Diabetes. Diabetes Technol Ther. Published 13 July 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →